(Bloomberg) -- The U.S. Food and Drug Administration won’t include outside specialists on its advisory panels if they have a personal financial stake of more than $50,000 in a company affected by a matter under discussion, the agency said.
(Bloomberg) -- The U.S. Food and Drug Administration won’t include outside specialists on its advisory panels if they have a personal financial stake of more than $50,000 in a company affected by a matter under discussion, the agency said.
